upload
U.S. Centers for Disease Control and Prevention
Industri: Government
Number of terms: 6326
Number of blossaries: 0
Company Profile:
Capable of transmitting infection. When persons who have clinically active pulmonary or laryngeal TB disease cough or sneeze, they can expel droplets containing M. tuberculosis into the air. Persons whose sputum smears are positive for AFB are probably infectious.
Industry:Health care
A medication that is usually administered by injection into the muscle (intramuscular (IM)) or the bloodstream (intravenous (IV)).
Industry:Health care
Therapy administered either two or three times per week, rather than daily. Intermittent therapy should be administered only under the direct supervision of an HCW or other designated person (see Directly observed therapy (DOT)).
Industry:Health care
Within the layers of the skin.
Industry:Health care
A first-line, oral drug used either alone as preventive therapy or in combination with several other drugs to treat TB disease.
Industry:Health care
An injectable, second-line anti-TB drug used primarily for treatment of drug-resistant TB.
Industry:Health care
Infection with M. tuberculosis, usually detected by a positive PPD skin-test result, in a person who has no symptoms of active TB and who is not infectious.
Industry:Health care
A group of closely related mycobacterial species that can cause active TB (e.g., M. tuberculosis, M. bovis, and M. africanum); most TB in the United States is caused by M. tuberculosis.
Industry:Health care
A method of skin testing that is performed by injecting 0.1 mL of PPD-tuberculin containing 5 tuberculin units into the dermis (i.e., the second layer of skin) of the forearm with a needle and syringe. This test is the most reliable and standardized technique for tuberculin testing (see Tuberculin skin test and Purified protein derivative (PPD)- tuberculin test).
Industry:Health care
Active TB caused by M. tuberculosis organisms that are resistant to more than one anti-TB drug; in practice, often refers to organisms that are resistant to both INH and rifampin with or without resistance to other drugs (see Drug resistance, acquired and Drug resistance, primary).
Industry:Health care